OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CHALLENGES OF TREATMENT-RESISTANT DEPRESSION
James Paul Pandarakalam
Psychiatria Danubina (2018) Vol. 30, Iss. 3, pp. 273-284
Open Access | Times Cited: 106

Showing 26-50 of 106 citing articles:

Photobiomodulation
Willians Fernando Vieira, Dan V. Iosifescu, Kayla Marie McEachern, et al.
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 331-348
Closed Access | Times Cited: 10

Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray
Ibrahim Turkoz, J. Craig Nelson, Samuel T. Wilkinson, et al.
Psychiatry Research (2023) Vol. 323, pp. 115165-115165
Open Access | Times Cited: 9

Hepatic metabolomics of the compatibility effect of Xiaoyaosan on CUMS-induced depression based on the TCM theory of “Treating Diseases via Regulating the Liver’s Function”
Xiaojie Liu, Huan-le Liu, Di Zhao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 201, pp. 114123-114123
Closed Access | Times Cited: 23

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
Soraia Silva, Joana Bicker, Carla Fonseca, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22

The prevalence and economic burden of treatment-resistant depression in Thailand
Jirada Prasartpornsirichoke, Nuttorn Pityaratstian, Chayanit Poolvoralaks, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8

Emerging roles of the unfolded protein response (UPR) in the nervous system: A link with adaptive behavior to environmental stress?
Mei-Li Díaz-Hung, Gabriela Martínez, Claudio Hetz
International review of cell and molecular biology (2020), pp. 29-61
Closed Access | Times Cited: 21

Deep brain stimulation improved depressive-like behaviors and hippocampal synapse deficits by activating the BDNF/mTOR signaling pathway
Zuoli Sun, Lina Jia, Dandan Shi, et al.
Behavioural Brain Research (2021) Vol. 419, pp. 113709-113709
Closed Access | Times Cited: 18

Irremediability in psychiatric euthanasia: examining the objective standard
Marie Nicolini, EJ Jardas, Carlos A. Zarate, et al.
Psychological Medicine (2022) Vol. 53, Iss. 12, pp. 5729-5747
Open Access | Times Cited: 13

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Yuriy M. Kositsyn, Murilo S. de Abreu, Tatiana O. Kolesnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9482-9482
Open Access | Times Cited: 7

Serum indoleamine 2, 3-dioxygenase and tryptophan-2, 3-dioxygenase: potential biomarkers for the diagnosis of major depressive disorder
Jun Liang, Zhuoyu Cheng, Feng Shan, et al.
Psychopharmacology (2024) Vol. 241, Iss. 5, pp. 1093-1099
Closed Access | Times Cited: 2

BDNF exon IV promoter methylation and antidepressant action: a complex interplay
Hansi Pathak, Anton Borchert, Sara Garaali, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 12

Prognostic Significance of Blood-Based Baseline Biomarkers in Treatment-Resistant Depression: A Literature Review of Available Studies on Treatment Response
Theano Gkesoglou, Stavroula I. Bargiota, Eleni Iordanidou, et al.
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 11

Explainable Multi-Layer Dynamic Ensemble Framework Optimized for Depression Detection and Severity Assessment
Dillan Imans, Tamer Abuhmed, Meshal Alharbi, et al.
Diagnostics (2024) Vol. 14, Iss. 21, pp. 2385-2385
Open Access | Times Cited: 2

The circadian machinery links metabolic disorders and depression: A review of pathways, proteins and potential pharmacological interventions
Eleni Pitsillou, Julia Liang, Andrew Hung, et al.
Life Sciences (2020) Vol. 265, pp. 118809-118809
Closed Access | Times Cited: 16

RISK OF A MAJOR DEPRESSIVE EPISODE IN ASTHMA AND COPD PATIENTS AMIDST COLOMBIAN SAR-COV-2 CONFINEMENT
Carmen Cecilia Caballero‐Domínguez, John Carlos Pedrozo‐Pupo, Adalberto Campo‐Arias
Psychiatria Danubina (2021) Vol. 33, Iss. 1, pp. 101-106
Open Access | Times Cited: 14

Downregulation of miR-383 reduces depression-like behavior through targeting Wnt family member 2 (Wnt2) in rats
Shanshan Liu, Qing Liu, Yanjie Ju, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13

Natural Language Processing-Based Quantication of the Mental State of Psychiatric Patients
Sankha Subhra Mukherjee, Jiawei Yu, Yida Won, et al.
Computational Psychiatry (2020) Vol. 4, pp. 76-76
Open Access | Times Cited: 14

Effects of Baihui electroacupuncture in a rat model of depression
Lin Mao, Feifei Lv, Yang Wenfu, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 24, pp. 1646-1646
Open Access | Times Cited: 13

Drug-drug salt forms of vortioxetine with mefenamic acid and tolfenamic acid
Lei Gao, Wenyan Zheng, Wei-Ling Yang, et al.
Journal of Molecular Structure (2022) Vol. 1268, pp. 133725-133725
Closed Access | Times Cited: 8

Scroll to top